Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Albin

Showing results (221-230 of 242) with videos related to

Pageof 25
Sort By:
Journal of Proteome Research|May 8, 2012
Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brainsVictor P Andreev, Vladislav A Petyuk, Heather M Brewer, et al.
Nature Communications|July 2, 2025
A multicenter longitudinal study of cholinergic subgroups in Parkinson diseaseNicolaas I Bohnen, Stiven Roytman, Sygrid van der Zee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2012
In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5PSergey N Zolov, Dave Bridges, Yanling Zhang, et al.
ACS Chemical Neuroscience|June 5, 2014
High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selectionMaria V Fawaz, Allen F Brooks, Melissa E Rodnick, et al.
Research Square|February 12, 2026
Cholinergic substrates of gait and postural impairments in Progressive Supranuclear PalsyPrabesh Kanel, Giulia Carli, Stiven Roytman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJason K Russell, Alexander C Conley, Brian Boyd, et al.
Neurobiology of Aging|February 6, 2025
Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [<sup>18</sup>F]-fluoroethoxybenzovesamicol positron emission tomography imagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [<sup>18</sup>F]-Fluoroethoxybenzovesamicol Positron Emission Tomography ImagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Journal of Neuropathology and Experimental Neurology|February 19, 2016
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center DatabaseJohn M Ringman, Sarah Monsell, Denise W Ng, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|February 23, 2017
Eighth International Chorea-Acanthocytosis Symposium: Summary of Workshop Discussion and Action PointsSamuel S Pappas, Juan Bonifacino, Adrian Danek, et al.
Pageof 25

Showing results (221-230 of 242) with videos related to

Sort By:
Pageof 25
Journal of Proteome Research|May 8, 2012
Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brainsVictor P Andreev, Vladislav A Petyuk, Heather M Brewer, et al.
Nature Communications|July 2, 2025
A multicenter longitudinal study of cholinergic subgroups in Parkinson diseaseNicolaas I Bohnen, Stiven Roytman, Sygrid van der Zee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2012
In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5PSergey N Zolov, Dave Bridges, Yanling Zhang, et al.
ACS Chemical Neuroscience|June 5, 2014
High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selectionMaria V Fawaz, Allen F Brooks, Melissa E Rodnick, et al.
Research Square|February 12, 2026
Cholinergic substrates of gait and postural impairments in Progressive Supranuclear PalsyPrabesh Kanel, Giulia Carli, Stiven Roytman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJason K Russell, Alexander C Conley, Brian Boyd, et al.
Neurobiology of Aging|February 6, 2025
Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [<sup>18</sup>F]-fluoroethoxybenzovesamicol positron emission tomography imagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Age-Related Changes in the Cholinergic System in Adults with Down Syndrome Assessed Using [<sup>18</sup>F]-Fluoroethoxybenzovesamicol Positron Emission Tomography ImagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Journal of Neuropathology and Experimental Neurology|February 19, 2016
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center DatabaseJohn M Ringman, Sarah Monsell, Denise W Ng, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|February 23, 2017
Eighth International Chorea-Acanthocytosis Symposium: Summary of Workshop Discussion and Action PointsSamuel S Pappas, Juan Bonifacino, Adrian Danek, et al.
Pageof 25